Literature DB >> 17389705

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Francesco Salerno1, Alexander Gerbes, Pere Ginès, Florence Wong, Vicente Arroyo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17389705      PMCID： PMC1954971          DOI： 10.1136/gut.2006.107789

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  80 in total

1.  Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide.

Authors:  A Castro; W Jiménez; J Clària; J Ros; J M Martínez; M Bosch; V Arroyo; J Piulats; F Rivera; J Rodés
Journal:  Hepatology       Date:  1993-08       Impact factor: 17.425

2.  Impact of pretransplant renal function on survival after liver transplantation.

Authors:  T A Gonwa; G B Klintmalm; M Levy; L S Jennings; R M Goldstein; B S Husberg
Journal:  Transplantation       Date:  1995-02-15       Impact factor: 4.939

3.  Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis.

Authors:  A Luca; J C García-Pagán; F Feu; J C Lopez-Talavera; M Fernández; C Bru; J Bosch; J Rodés
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

4.  Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction.

Authors:  A Maroto; P Ginès; V Arroyo; A Ginès; J Saló; J Clària; W Jiménez; C Bru; F Rivera; J Rodés
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

Review 5.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Authors:  V Arroyo; P Ginès; A L Gerbes; F J Dudley; P Gentilini; G Laffi; T B Reynolds; H Ring-Larsen; J Schölmerich
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

6.  The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.

Authors:  P P Michielsen; G E Boeckxstaens; S U Sys; A G Herman; P A Pelckmans
Journal:  J Hepatol       Date:  1995-09       Impact factor: 25.083

7.  Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.

Authors:  A Follo; J M Llovet; M Navasa; R Planas; X Forns; A Francitorra; A Rimola; M A Gassull; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

8.  Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

Authors:  J Stange; W Ramlow; S Mitzner; R Schmidt; H Klinkmann
Journal:  Artif Organs       Date:  1993-09       Impact factor: 3.094

9.  Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

Authors:  A Ginès; A Escorsell; P Ginès; J Saló; W Jiménez; L Inglada; M Navasa; J Clària; A Rimola; V Arroyo
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

10.  Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis.

Authors:  M Hartleb; R Moreau; S Cailmail; C Gaudin; D Lebrec
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682
View more
  228 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

3.  Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.

Authors:  Zhen-Yong Shao; Lu-Nan Yan; Wen-Tao Wang; Bo Li; Tian-Fu Wen; Jia-Yin Yang; Ming-Qing Xu; Ji-Chun Zhao; Yong-Gang Wei
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

4.  Hepatorenal syndrome: is it the magnitude of the renal failure that matters?

Authors:  Marco A Olivera-Martínez; Marius C Florescu
Journal:  Dig Dis Sci       Date:  2012-02-24       Impact factor: 3.199

Review 5.  Hepatorenal syndrome: Update on diagnosis and treatment.

Authors:  Olga Baraldi; Chiara Valentini; Gabriele Donati; Giorgia Comai; Vania Cuna; Irene Capelli; Maria Laura Angelini; Maria Ilaria Moretti; Andrea Angeletti; Fabio Piscaglia; Gaetano La Manna
Journal:  World J Nephrol       Date:  2015-11-06

6.  Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.

Authors:  Pi-Qi Zhou; Shao-Ping Zheng; Min Yu; Sheng-Song He; Zhi-Hong Weng
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

7.  Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?

Authors:  Waheed Abdelmonsef Mahmoud; Nadia Abdelaaty Abdelkader; Amal Mansor
Journal:  Indian J Gastroenterol       Date:  2013-11-29

8.  Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.

Authors:  Anna Licata; Marcello Maida; Ambra Bonaccorso; Fabio Salvatore Macaluso; Maria Cappello; Antonio Craxì; Piero Luigi Almasio
Journal:  World J Hepatol       Date:  2013-12-27

Review 9.  Renal dysfunction in cirrhosis.

Authors:  Nathalie H Urrunaga; Ayse L Mindikoglu; Don C Rockey
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

10.  Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

Authors:  Juan P Arab; Juan C Claro; Juan P Arancibia; Jorge Contreras; Fernando Gómez; Cristian Muñoz; Leyla Nazal; Eric Roessler; Rodrigo Wolff; Marco Arrese; Carlos Benítez
Journal:  World J Hepatol       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.